本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Eagle制药

1.94
0.0000
成交量:- -
成交额:- -
市值:2,526.49万
市盈率:2.13
高:1.94
开:1.94
低:1.94
收:1.94
数据加载中...
2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/27

重要事件披露

Form 8-K - Current report
2024/11/26

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/05

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/10/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/02

重要事件披露

Form 8-K - Current report
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/05

重要事件披露

Form 8-K - Current report